These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28657917)

  • 21. [Treatment of spastic upper limb with botulinum toxin].
    Dénes Z; Fehér M; Várkonyi A
    Ideggyogy Sz; 2007 May; 60(5-6):245-50. PubMed ID: 17578272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of incobotulinumtoxinA for the treatment of adult lower-limb post-stroke spasticity, including pes equinovarus.
    Bensmail D; Wissel J; Laffont I; Simon O; Scheschonka A; Flatau-Baqué B; Dressler D; Simpson DM
    Ann Phys Rehabil Med; 2021 Mar; 64(2):101376. PubMed ID: 32294561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience in using xeomin in the treatment of arm and hand spasticity in the early rehabilitation phase of stroke].
    Kostenko EV; Petrova LV; Ganzhula PA; Lisenker LN; Otcheskaia OV; Khozova AA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2):29-34. PubMed ID: 22677662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OnabotulinumtoxinA Improves Pain in Patients With Post-Stroke Spasticity: Findings From a Randomized, Double-Blind, Placebo-Controlled Trial.
    Wissel J; Ganapathy V; Ward AB; Borg J; Ertzgaard P; Herrmann C; Haggstrom A; Sakel M; Ma J; Dimitrova R; Fulford-Smith A; Gillard P
    J Pain Symptom Manage; 2016 Jul; 52(1):17-26. PubMed ID: 27037050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke.
    Santamato A; Micello MF; Ranieri M; Valeno G; Albano A; Baricich A; Cisari C; Intiso D; Pilotto A; Logroscino G; Panza F
    J Neurol Sci; 2015 Mar; 350(1-2):1-6. PubMed ID: 25684341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A
    J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects on walking of simultaneous upper/lower limb abobotulinumtoxina injections in patients with stroke or brain injury with spastic hemiparesis.
    McAllister PJ; Khatkova SE; Faux SG; Picaut P; Raymond R; Gracies JM
    J Rehabil Med; 2019 Oct; 51(10):813-816. PubMed ID: 31529136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
    Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
    Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
    Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
    Hubble J; Schwab J; Hubert C; Abbott CC
    Clin Neuropharmacol; 2013; 36(4):122-7. PubMed ID: 23783005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.
    Borg J; Ward AB; Wissel J; Kulkarni J; Sakel M; Ertzgaard P; Åkerlund P; Reuter I; Herrmann C; Satkunam L; Wein T; Girod I; Wright N;
    J Rehabil Med; 2011 Jan; 43(1):15-22. PubMed ID: 21174051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world differences in dosing and clinical utilization of OnabotulinumtoxinA and AbobotulinumtoxinA in the treatment of upper limb spasticity.
    Bohart Z; Dashtipour K; Kim H; Schwartz M; Zuzek A; Singh R; Nelson M
    Toxicon; 2024 Apr; 241():107678. PubMed ID: 38447766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Post-stroke spasticity of the lower limb: a comprehensive rehabilitation of patients with the use of botulinum toxin (onabotulinumtoxin A)].
    Kostenko EV; Petrova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):39-48. PubMed ID: 25591515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The study of the efficacy of Botulinum toxin type A in patients with poststroke upper-limb spasticity ULIS-II: an analysis of Russian patients].
    Khat'kova SE; Khasanova DR; Korenko LA; Antipova LN; Shperling LP; Popov DV; Pokhabov DV; Poznyakova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):89-97. PubMed ID: 26356520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult Spasticity International Registry Study: methodology and baseline patient, healthcare provider, and caregiver characteristics.
    Francisco GE; Bandari DS; Bavikatte G; Jost WH; Adams AM; Largent J; Esquenazi A
    J Rehabil Med; 2017 Aug; 49(8):659-666. PubMed ID: 28805237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of long-term, poststroke, upper-limb spasticity with onabotulinumtoxinA.
    Patel AT
    Phys Ther; 2011 Nov; 91(11):1636-41. PubMed ID: 21868610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.